Skip to main content
Log in

Adipositas – Risikofaktor für onkologische Erkrankungen

Obesity – risk factor for malignancies

  • Leitthema
  • Published:
Der Gynäkologe Aims and scope

Zusammenfassung

Die Prävalenz der Adipositas nimmt weltweit rapide zu. Die gesundheitlichen und ökonomischen Konsequenzen dieser Entwicklung sind bedeutsam, da Adipositas mit zahlreichen Erkrankungen assoziiert ist. Neben einer Erhöhung des Risikos für Typ-II-Diabetes und kardiovaskuläre Erkrankungen bestätigen große prospektive Studien, dass Übergewicht die Inzidenz und Mortalität einer Reihe von bösartigen Tumoren erhöht. Zu diesen zählen die Karzinome des Kolons, der Mamma (postmenopausal) und des Endometriums sowie das Nierenzellkarzinom und Adenokarzinome des Ösophagus. Die gesteigerte Insulinresistenz und die daraus resultierende chronische Hyperinsulinämie, die höhere Bioverfügbarkeit von Steroidhormonen und lokale Entzündungsprozesse werden als potenzielle Mechanismen für die adipositasassoziierte Entstehung und Progression von Tumoren angeführt. Auch einige aus dem Fettgewebe stammende Hormone, Adipozytokine, scheinen die Karzinogenese zu beeinflussen. Vieles deutet darauf hin, dass diätetische Interventionsstrategien das Risiko für Krebserkrankungen vermindern und die Prognose verbessern.

Abstract

The prevalence of obesity is rapidly increasing worldwide. The consequences of this development for health and economy are important, since obesity is associated with many diseases. In addition to an increase in the risk of type II diabetes and cardiovascular disease, large prospective studies confirm that excess body weight also increases the incidence and mortality of a number of malignancies including cancers of the colon, female breast (postmenopausal), endometrium, kidney (renal cell), and esophagus (adenocarcinoma). The potential mechanisms by which obesity induces or promotes tumorigenesis include insulin resistance and resultant chronic hyperinsulinaemia, as well as increased bioavailability of steroid hormones and localized inflammation. Moreover, some of the adipose tissue-derived hormones have been proposed to influence carcinogenesis. There is growing evidence that dietary intervention strategies may reduce risk and improve prognosis of cancer diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Adams TD, Stroup AM, Gress RE et al (2009) Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring) 17(4):796–802

    Google Scholar 

  2. Belfiore A, Frasca F, Pandini G et al (2009) Insulin receptor isoforms and insulin receptor/insulin-like growth factor hybrids in physiology and disease. Endocr Rev 30:586–623

    Article  PubMed  CAS  Google Scholar 

  3. Birmingham JM, Busik JV, Hansen-Smith FM, Fenton JI (2009) Novel mechanisms for obesity-induced colon cancer progression. Carcinogenesis 30:690–697

    Article  PubMed  CAS  Google Scholar 

  4. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638

    Article  PubMed  Google Scholar 

  5. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579–591

    Article  PubMed  CAS  Google Scholar 

  6. Chlebowski RT, Blackburn GL, Thomson CA et al (2006) Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women’s Intervention Nutrition Study. J Natl Cancer Inst 98(24):1767–1776

    Article  PubMed  Google Scholar 

  7. Cohen SS, Palmieri RT, Nyante SJ et al (2008) Obesity and screening for breast, cervical, and colorectal cancer in women: a review. Cancer 112:1892–1904

    Article  PubMed  Google Scholar 

  8. Eliassen AH, Colditz GA, Rosner B et al (2006) Adult weight change and risk of postmenopausal breast cancer. JAMA 296(2):193–201

    Article  PubMed  CAS  Google Scholar 

  9. Emons G, Gründker C, Hanf V (2003) Sind Östrogene Karzinogene? Gynakologe 36:182–189

    Google Scholar 

  10. Ewertz M, Jensen MB, Gunnarsdottir KA et al (2011) Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 29(1):25–31

    Article  PubMed  Google Scholar 

  11. Kaaks R, Lukanova A, Kurzer MA (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomark Prev 11:1531–1543

    CAS  Google Scholar 

  12. Kroenke C, Chen W, Rosner B et al (2005) Weight, weight gain, and survival after breast cancer diagnosis. J Appl Physiol 23:1370–1378

    Google Scholar 

  13. Maruthur NM, Bolen SD, Brancati FL, Clark JM (2009) The association of obesity and cervical cancer screening: a systematic review and meta-analysis. Obesity 17:375–381

    PubMed  Google Scholar 

  14. Million Women Study Collaborators (2005) Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 365:1543–1551

    Article  Google Scholar 

  15. Nock NL, Berger NA (2010) Obesity and cancer: Overview of mechanisms. In: Berger NA (ed) Cancer and energy balance, epidemiology and overview. Springer, Berlin Heidelberg New York Tokyo, pp 129–179

  16. Pfeiler G, Königsberg R, Gnant M (2011) Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the prospective ABCSG-12 Trial. J Clin Oncol 29(19):2653–2659

    Article  PubMed  CAS  Google Scholar 

  17. Polednak AP (2008) Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers. Cancer Detect Prev 32:190–199

    Article  PubMed  Google Scholar 

  18. Prospective Studies Collaboration, Whitlock G, Lewington S et al (2009) Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet 373:1083–1096

    Article  Google Scholar 

  19. Pugeat M et al (1991) Pathophysiology of sex hormone binding globuline (SHGB): relation to insulin. J Steroid Biochem Mol Biol 40:841–849

    Article  PubMed  CAS  Google Scholar 

  20. Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systemic review and meta-analysis of prospective observational studies. Lancet 371:569–578

    Article  PubMed  Google Scholar 

  21. Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev med 6:301–316

    Article  Google Scholar 

  22. Schouten LJ, Rivera C, Hunter DJ et al (2008) Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 17(4):902–912

    Article  PubMed  Google Scholar 

  23. Sjöström L, Gummesson A, Sjöström CD et al (2009) Swedish Obese Subjects Study. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 10(7):653–662

    Article  PubMed  Google Scholar 

  24. Statistisches Bundesamt Deutschland (2010) Pressemitteilung Nr. 194 vom 02.06.2010

  25. Suhrcke M et al (2005) Economic consequences of chronic diseases and the economic rationale for public and private intervention. Oxford Health Alliance, London

  26. The Endogenous Hormones and Breast Cancer Collaborative Group (2010) Insulin-like growth factor 1 (IGF 1), IGF binding protein 3 (IGFBP 3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11:530–542

    Article  Google Scholar 

  27. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A et al (1995) A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 87(3):190–197

    Article  PubMed  CAS  Google Scholar 

  28. Trentham-Dietz A, Nichols HB, Hampton JM, Newcomb PA (2006) Weight change and risk of endometrial cancer. Int J Epidemiol 35(1):151–158

    Article  PubMed  CAS  Google Scholar 

  29. Vainio H, Bianchini F (eds) (2002) IARC Handbooks of cancer prevention: Weight control & physical activity. IARC, Lyon, France

  30. Van Kruijsdijk RC, Wall E van der, Visseren FL (2009) Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarakers Prev 18:2569–2578

    Article  Google Scholar 

  31. WHO (1998) Preventing and managing the global epidemic. Report of a WHO consultation on obesity. WHO, Geneva

  32. World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity and the prevention of cancer: a global perspective. AICR, Washington DC

  33. World Health Organization (2011) Obesity and overweight. Fact sheet No 311March 2011. http://www.who.int/mediacentre/factsheets/fs311/en/index.html#

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Hawighorst.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaczerowsky, A., Emons, G. & Hawighorst, T. Adipositas – Risikofaktor für onkologische Erkrankungen. Gynäkologe 44, 885–890 (2011). https://doi.org/10.1007/s00129-011-2834-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-011-2834-3

Schlüsselwörter

Keywords

Navigation